CompoAtlas

VITALITE 50+ et SENIOR

Food supplement declared in France, decision dated 11 August 2025

VITALITE 50+ et SENIOR (PHARMA BEST) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
PHARMA BEST
Food business operator placing the product on the market
L.I.N
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Gélule
Daily dose
1 gélule
Directions for use
Prendre 1 gélule par jour
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Femmes enceintes, Sous antidiabétiques

Declaration 338272, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

None of the rules we check applies to the declared ingredients.

Declared composition

Plants

PlantPartPreparationPer day
Panax ginseng C.A.Mey.RacineAutre extrait sec20 mg
Vaccinium myrtillus L.BaieAutre extrait sec1 mg

Substances

NamePer day
lutéinenot declared

Micro-organisms

StrainPer day
Lactobacillus Gasseri HLG1310 (unit not declared)
Bifidobacterium Infantis HBL7910 (unit not declared)
Bifidobacterium Bifidum BB6710 (unit not declared)

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
D-pantothénate de calciumAcide pantothénique (vitamine B5)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
D-biotineBiotine (vitamine B8)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
Béta-carotèneBêta-carotènepas de limite (données insuffisantes)aucune dose fixée
Picolinate de chromeChromepas de limite (données insuffisantes)25 µg
Bisglycinate ferreuxFer40 mg (niveau de sécurité)14 mg
L-méthylfolate de calciumFolates (vitamine B9)1,000 µg200 µg
Iodure de potassiumIode600 µg150 µg
Citrate de manganèseManganèse8 mg (niveau de sécurité)3.5 mg
Molybdate de sodiumMolybdène600 µg150 µg
NicotinamideNicotinamide (vitamine B3)900 mg54 mg
Levure enrichie en séléniumSélénium255 µg50 µg
Chlorhydrate de thiamineVitamine B1 (thiamine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
CyanocobalamineVitamine B12pas d'effet indésirable définidose annulée par le Conseil d'État en 2011
RiboflavineVitamine B2 (riboflavine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
Chlorhydrate de pyridoxineVitamine B612 mg2 mg
Acide L-ascorbiqueVitamine Cpas de limite (données insuffisantes)180 mg
CholécalciférolVitamine D100 µg (4,000 UI)5 µg (200 UI)
Acétate de D-alpha-tocophéryleVitamine E300 mg30 mg
Picolinate de zincZinc25 mg15 mg

Additives

E530, E470b, E414

Other ingredients

Gélule végétale

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé aux femmes enceintes ou qui allaitent, aux adolescents de moins de 18 ans et aux personnes sous antidiabétiques.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Panax ginseng C.A.Mey.
    Read the warning, when it applies and the studies cited

    PANAX GINSENG

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Brinker 2010; Vuksan et al. 2008; Seely et al. 2008; Sievenpiper et al. 2006; ESCOP 2003; Tetsutani et al. 2000; Sotaniemi et al. 1995; Chin 1991).

    8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking antidepressant medication, blood thinners or digoxin (Brinker 2010; Lee et al. 2008a; Dasgupta and Reyes 2005; Janetzki and Morreale 1997; Gonzalez-Seijo et al. 1995; Shader and Greenblatt 1988; Jones and Runikis 1987; Shader and Greenblatt 1985).

    8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Condition of application: Traditional Chinese Medicine.

    Do not use in cases of yin deficiency with heat signs, heat excess, or in the absence of significant qi deficiency (Bensky et al. 2004).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience insomnia, anxiety or headaches (Lee et al. 2008b; Vuksan et al 2008; de Andrade et al.2007; Sievenpiper et al. 2006; Coon and Ernst 2002; Ellis and Reddy 2002; Scaglione et al. 2001; Siegel 1979).

    8 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 27 June 2025

  • Vaccinium myrtillus L.
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : PHARMA BEST

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line